Factors | Overall (n = 78) | CR + R (n = 65) | NR (n = 13) | P * |
---|---|---|---|---|
Gender (Female/Male) | 44/34 (56.4%/43.6%) | 36/29 (55.4%/44.6%) | 8/5 (61.5%/38.5%) | 0.683 |
Age, yr., median, (range) | 43.8 (14.2~ 77.5) | 42.7 (14.2–69.0) | 49.4 (35.0–77.5) | 0.013 |
Duration of disease, yr., median (range) | 12 (6–132) | 18 (6–78) | 4 (1–132) | 0.370 |
Response to corticosteroid (yes:no) | 58:20 | 50:15 | 8:5 | 0.246 |
PLT count, 109/L, median (range) | ||||
PRD 1 | 44.0 (4.0–394.0) | 47.0 (22.0–394.0) | 21.0 (4.0–138.0) | 0.001 |
POD 1 | 93.0 (21.0–415.0) | 94.0 (59–415.0) | 88.0 (21.0–156.0) | 0.681 |
POD 3 | 195.0 (112.0–422.0) | 198.0 (112.0–422.0) | 188.0 (123.0–415.0) | 0.503 |
POD 7 | 250.0 (189.0–592.0) | 250.0 (189.0–592.0) | 244.0 (191.0–514.0) | 0.489 |
Operative time, minutes, median (range) | 146.0 (65.0~ 280.0) | 165.0 (65.0–201.0) | 139.0 (110.0–189.0) | 0.305 |
Intraoperative blood loss, ml, median (range) | 200 (10–1200) | 200 (10–650) | 280 (50–1200) | 0.006 |
Accessory spleen (yes: no) | 6:72 | 6:59 | 0:13 | 0.583 |
Peroerpative complications (yes:no) | 7:71 | 5:60 | 2:11 | 0.056 |